- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ 38518168
Total 1097 results
-
Janssen Pharmaceutical K.K.RecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorJapan
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Rabin Medical CenterJanssen, LPRecruitingCentral Nervous System LymphomaIsrael
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States, Taiwan, Czechia, Spain, Mexico, South Africa, Colombia, Russian Federation, Brazil, Bulgaria, Sweden
-
ActelionTerminatedPulmonary Arterial HypertensionGermany, Korea, Republic of, Israel, Singapore, United States, Russian Federation, Brazil, Netherlands, Malaysia, Saudi Arabia, United Kingdom, Hong Kong, France, United Arab Emirates, Argentina
-
Janssen Research & Development, LLCCompleted
-
Octimet Oncology N.V.Terminated
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen R&D IrelandTerminatedChronic Hepatitis C InfectionGermany
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisUnited States, Korea, Republic of, Taiwan, Germany, Poland, Brazil, Spain, Hungary, Australia, Canada, Romania
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Belgium, Korea, Republic of, Germany, Italy, France, Spain, Canada, United Kingdom, Greece, Japan, Australia, Netherlands, Portugal, Russian Federation, Ukraine
-
Janssen Research & Development, LLCWithdrawn
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Research & Development, LLCCompletedMajor Depressive Disorder With Anxious DistressUnited States, Moldova, Republic of, Russian Federation, Ukraine, United Kingdom
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited Kingdom, Germany, Spain, Netherlands
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteSwitzerland, France
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States, Bulgaria, Ukraine, Russian Federation, Germany, Finland, Japan, France
-
Janssen Research & Development, LLCCompletedHealthyBelgium, Netherlands
-
Royal Marsden NHS Foundation TrustJanssen, LPUnknownGastrooesophageal CancerUnited Kingdom
-
Furiex Pharmaceuticals, IncCompletedIrritable Bowel SyndromeUnited States, Canada, United Kingdom
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisKorea, Republic of, United States, Brazil, Japan, Spain, Argentina, Hungary, Poland, United Kingdom, Australia, Taiwan, Canada, Germany
-
Janssen Pharmaceutical K.K.CompletedMyelodysplastic SyndromeJapan
-
National Cancer Institute (NCI)Not yet recruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
ActelionRecruitingHypertension, PulmonaryKorea, Republic of, Taiwan, Poland, Bulgaria, Ukraine, Belgium, South Africa, Belarus, Russian Federation
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Janssen Research & Development, LLCCompletedMultiple MyelomaCanada, United States, Czechia, Israel, Italy, Korea, Republic of, Brazil, United Kingdom, Japan, Taiwan, Australia, Poland, Spain, France, Russian Federation, Sweden, Ukraine, Greece
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial VirusCanada, United Kingdom, Spain, Brazil, Sweden, Poland, Australia, Finland
-
Janssen-Cilag, S.A.Completed
-
Janssen Research & Development, LLCCompletedCrohn DiseaseUnited States, France, Poland, Ukraine, Germany, Belgium, Bulgaria, Romania, Japan, Canada, Korea, Republic of, Russian Federation, Hungary, United Kingdom
-
Janssen Research & Development, LLCGenentech, Inc.CompletedCarcinoma, Non-Small-Cell LungFrance, United States, Spain, Hungary, Poland
-
Janssen Research & Development, LLCCompletedHealthy ParticipantsBelgium
-
Janssen Sciences Ireland UCCompletedRespiratory Syncytial Virus InfectionsUnited Kingdom
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingInvasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) PreventionUnited States, Poland, Belgium, Canada
-
Janssen Research & Development, LLCTerminatedRespiratory Syncytial VirusesAustralia, France, United Kingdom, Belgium, Taiwan, United States, Spain, Argentina, Mexico, Bulgaria, Malaysia, Japan, Sweden, Korea, Republic of, Canada, Netherlands, Brazil, Germany, Poland
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHealthy | Pharmacokinetics